Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASEL | Q05823 | 7/20 | 0.58 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.56 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.55 |
| ▸ | SRC | P12931 | 1/20 | 0.55 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.55 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.55 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.55 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21417372 | 0.94 | RNASEL (0.66) | RNASELP2RY1SRCP2RY2 | |
| SCHEMBL22352060 | 0.94 | RNASEL (0.65) | RNASELP2RX3P2RY1SRCP2RY2 | |
| SCHEMBL23477159 | 0.91 | RNASEL (0.56) | RNASEL | |
| SCHEMBL24771772 | 0.91 | RNASEL (0.56) | RNASEL | |
| SCHEMBL23477028 | 0.90 | FUT5 (0.58) | RNASELP2RX3P2RY2 | |
| SCHEMBL24703982 | 0.88 | RNASEL (0.75) | RNASELP2RY1SRCP2RY2 | |
| SCHEMBL19696038 | 0.86 | RNASEL (0.61) | RNASEL | |
| SCHEMBL16727889 | 0.86 | P2RX3 (0.68) | RNASELP2RX3 | |
| SCHEMBL18087247 | 0.86 | P2RX3 (0.68) | RNASELP2RX3 | |
| SCHEMBL25552773 | 0.86 | TGM2 (0.60) | RNASELP2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10011630-B2 | Cyclic dinucleotides for cytokine induction | INVIVOGEN (FR) | 2018-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10011630-B2 | Cyclic dinucleotides for cytokine induction | IL1B, IFNG, IFNAR1 | RNASEL 703/4885P2RX3 1368/4885P2RY1 179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.